Stock

GE HealthCare Technologies

GEHC

Medical - Devices · Healthcare

Price

$69.57

-0.78 (-1.11%)

Market Cap

$31.42B

Exchange

NASDAQ

Winston Score

Winston is serious

Mixed quality — meaningful strengths and weaknesses.

Data as of Oct 18, 2026 · filings through Jun 30, 2026

§How the score breaks down

Quality

Good

17/30

Growth

Mixed

6/20

Cash Flow

Good

5/10

Stability

Good

6/10

Valuation

Strong

8/10

Ownership

Weak

1/15

Dividends

Mixed

2/5

45 of 100 counted points = Winston Score 45.

Track this stock — start free trial

Share count rising — dilution

+1.2% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 454.7M (2021) → 460.3M (2025)

§Winston Score History

The full picture

GE HealthCare makes medical imaging machines and healthcare technology used by hospitals and clinics around the world. Its core products include MRI scanners, CT scanners, ultrasound machines, and X-ray equipment, along with software that helps doctors read and manage medical images. The company was spun off from General Electric in early 2023 and is one of the largest medical imaging companies globally.

GE HealthCare earns money by selling large imaging machines to hospitals, then generating recurring revenue through service contracts, software subscriptions, and replacement parts. It operates in over 160 countries, with significant revenue coming from North America, Europe, and China. Its installed base of equipment creates a natural moat, since hospitals tend to stick with the same vendor for maintenance and upgrades. The main risk is its exposure to China, where slower hospital spending and local competition from domestic manufacturers could pressure future growth.

Politician Trades

38 trades / 12mo

23 Congressional buys and 15 sells on GEHC in the last 12 months.

Unlock the full Smart Money Map — every trade plotted on the price chart with politicians, amounts and returns since each trade. Founder's Deal is $57/mo locked for life.

Unlock politician trades

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+5.8% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

+17.0% YoY

YoY Growth Rate

Steady EPS growth

R&D Spend

$1.3B/ year

→ Flat (-4% vs prior year)

6.1% of revenue

Below sector average (18%)

Steady R&D investment year-over-year

Insider Activity

0.3%ownership

→ Flat

Insider ownership roughly steady over the past year

Cash Runway

~10 months

$2.1B cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Short runway — potential dilution ahead through share issuance

Cash watch

GE HealthCare Technologies has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

41.2%

Healthy — 41.2% gross margin

Profit after running costs

Operating Margin

14.0%

Healthy — 14.0% operating margin

Return on the money invested

ROCE

12.2%

Good — 12.2% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

+1.4%

Nearly flat sales (+1.4% YoY)

Profit growth

EPS YoY

-29.0%

Earnings shrinking (-29.0% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

How steady the profit is

EPS Consistency

5/8 quarters

Mixed — about half the quarters showed growth

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

89%

Modest — 89% of profit becomes cash

Spare cash per sale

FCF Margin

4.4%

Thin free cash flow (4.4%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

0.92

Moderate — manageable debt (0.92)

Covers its interest

Interest Cover

5.90x

Adequate interest coverage (5.9x)

Interest coverage between 3 and 8. Profits cover interest several times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

20.0x

Fair value — P/E 20.0

P/E in the normal range. Price is roughly $15 for every $1 of yearly profit.

Cheaper or dearer next year

P/E vs Forward

+9.3

GROWING

Earnings expected to grow meaningfully — cheaper on forward P/E (20.0 → 10.7)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend

Dividend Yield

0.25%

Small dividend — 0.25% yield

Modest yield. The bulk of any return needs to come from price appreciation.

Dividend record

Dividend Growth

+3.6%

Dividend growing modestly (3.6% YoY)

Payout Ratio

no trend

Pays out a modest share of profit and keeps the rest to reinvest. Room to keep paying through a weak year.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial